GO
Loading...

Actelion Raises Its 2012 Profit View

Thursday, 19 Jul 2012 | 1:40 AM ET

Andrew Oakley, CFO of Actelion the Swiss Biotech firm, told CNBC, "Market pressures aren't going to go away but we have factored them all in and what we have seen in the first six months have confirmed we are where we thought we would be."